Parkinsons disease Flashcards

1
Q

what is parkinsons disease?

A

Parkinson’s disease is a common and complex neurological disorder, affecting mainly movement
causes by loss of dopaminergic neurones in the substantia nigra.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are motor symptoms of parkinsons?

A

Bradykinesia (slowed movement):
Slowness of walking and other movements
Reduced armswing or stride length
Reduced facial reaction (“masked face”
Softer or slurred speech
Smaller handwriting

Muscular rigidity
Stiffness of limb(s)
Sometimes associated with pain

Rest Tremor
Tremor in one limb with the limb at rest
Tremor with holding a posture or with action
asymmetric

Imbalance
Loss of balance reflexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are non-motor symptoms?

A

Autonomic dysfunction:
Orthostatic hypotension
Urogenital dysfunction
Constipation
Heat or cold intolerance

Sleep disorders:
Sleep fragmentation
Insomnia
REM sleep behaviour disorder (RBD)
Sleep attacks

Neuropsychiatric disorders:
Fatigue
Anhedonia
Depression and anxiety
Dementia

Sensory disorders:
Pain
Colourvision deficits
Abnormal sensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the role of dopamine on a patient with parkinsons

A

Dopamine is critical for control of movement and acts as a neurotransmitter in the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dopamine effect on synaptic levels?

A

substantia nigra located in mid brain
dopamine reaches the sub thalamic nucleus , putamen, globus palidus into the thalamus into the cortex
with positive and negative dopamine signals- it will initiate movement .

Action potential occurs at synaptic levels
Vesicles fuse with synaptic membrane
Dopamine is released
Dopamine binds to dop receptor - d1 and d2
Transmitting signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the two key pathological hallmark of parkisons?

A

Loss of neurons, predominantly dopaminergic and in the Substantia nigra (when pigmented (intracellular inclusion) - up to 70% cell is gone when diagnosed)

The accumulation of intracellular inclusions, called Lewy bodies, made up of the protein alpha synuclein = become toxic = make neurone die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the causes of parkinsons disease?

A

Unknown cause in most cases (idiopathic or sporadic disease)

Specific environmental triggers
Genetic component

environment - pesticides exposure, MPTP exposure - crosses the blood-brain barrier which is toxic for mitochondria, exposure to influenza and repeated head trauma,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does MPTP effect and its importance?

A

MPTP exposure - crosses the blood-brain barrier which is toxic for mitochondria
which is essential for energy for the cells - to do functions .
dynamic - fuse together when there is high demand of energy
can be transported to areas of high energy needed areas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the genetic factors?

A

5 % familiar
95 % sporadic

2 components
- Inherited forms of Parkinson’s disease
- Genetic susceptibility in sporadic Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is an example of a gene which is involved in Parkinsons diease?

A

PINK1 - mitochondria dysfunction leading to parkinsons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the pharmacological treatment of parkinsons disease?

A

Disease modifying therapies
Existing therapies for PD are exclusively symptomatic

(dopamine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are non-pharmacological treatment?

A

Surgical interventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the dopamine pathway

A

tyrosine converted to l-dopa which converted into dopamine
Dopamine stored in vesicle
AP cause
Vesicle will fuse
Neurotransmitters will release and bind to receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

does dopamine or l-dopa move into the blood brain barrier

A

Dopamine does not cross blood brain barrier
L-dopa can cross blood brain barriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dopamine pathway treatments

L-DOPA is ~90% converted by DDC in intestinal wall
- Given with peripherally-acting DDC inhibitors, carbidopa or benserazide

L-DOPA also ~5% metabolised by plasma Catechol O-Methyl Transferase
- COMT inhibitor, entacapone, may be used as adjunct

Ensure majority of L-DOPA enters brain unchanged for conversion to DA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the first drug used for the most effective at symptom relief
examples

A

L-DOPA the first drug used and most effective at symptom relief

Common preparations:
carbidopa/levodopa (co-careldopa) (e.g. Sinemet, Parcopa, duodopa)
benserazide/levodopa
(co-beneldopa) (e.g. Madopar)
carbidopa, levodopa and entacapone (Stalevo)

Dopamine agonist (e.g. pramipexole) are also approved and in clinical use

17
Q

what are the Dopamine pathway side effects

A

Drugs treat symptoms but do not deal with underlying causes (replace dopamine but do not alter cell death)

common side effects = nausea, dizziness, headache and somnolence

Acute = psychosis
Chronic = excess movements (dyskinesia)

18
Q

what are the disadvantages of surgical interventions

A

Very expensive
Not available to most patients

19
Q

what is stem cell therapy in parkinsons diease?
Still in clinical trails

A
  • Replacement of cells in the basal ganglia to correct the underlying cause of lowered dopamine levels
  • Key question is what cells to use: initial studies used fetal brain cells (from aborted embryos), more recently embryonic stem cells and induced pluripotent cells have been suggested as alternatives